----------------------------------------------------------
Date of visit
-----------------------------
----------------------------------------------------------
Informed Consent
-----------------------------
----------------------------------------------------------
Demographics
-----------------------------
----------------------------------------------------------
Child Bearing Potential
-----------------------------
----------------------------------------------------------
History of cutaneous leishmaniasis
-----------------------------
----------------------------------------------------------
Eligibility
-----------------------------
----------------------------------------------------------
Medical Or Surgical History (other than Leishmaniasis)
-----------------------------
----------------------------------------------------------
Vein Assesment
-----------------------------
----------------------------------------------------------
Urinary drug screen
-----------------------------
----------------------------------------------------------
Pregnancy test
-----------------------------
----------------------------------------------------------
Clinical Laboratory - Test Hematology
-----------------------------
----------------------------------------------------------
Clinical Laboratory Test - Clinical Chemistry
-----------------------------
----------------------------------------------------------
Clinical Laboratory Test - Coagulation
-----------------------------
----------------------------------------------------------
Immunoassay (Thyroid Stimulating Hormone)
-----------------------------
----------------------------------------------------------
Urinalysis
-----------------------------
----------------------------------------------------------
Urine Microscopic Examination
-----------------------------
----------------------------------------------------------
Virology
-----------------------------
----------------------------------------------------------
Lesion Measurement
-----------------------------
----------------------------------------------------------
Physical Examination
-----------------------------
----------------------------------------------------------
Vital Signs
-----------------------------
----------------------------------------------------------
12-Lead ECG
-----------------------------
----------------------------------------------------------
Covid 19 testing
-----------------------------
----------------------------------------------------------
Alcohol Screen
-----------------------------
----------------------------------------------------------
Clinical Laboratory Test - Clinical Chemistry D-1
-----------------------------
----------------------------------------------------------
Interleukin-6
-----------------------------
----------------------------------------------------------
Titration Of Auto-Antibodies
-----------------------------
----------------------------------------------------------
Injection Site Examination
-----------------------------
----------------------------------------------------------
PBMC Isolate
-----------------------------
----------------------------------------------------------
Pharmacokinetic Blood Sampling (PK)
-----------------------------
----------------------------------------------------------
Pharmacodynamic Blood Sampling (PD) -Cytokines/Chemokines
-----------------------------
----------------------------------------------------------
mRNA Markers
-----------------------------
----------------------------------------------------------
CpG ODN D35 Administration
-----------------------------
----------------------------------------------------------
Miltefosine Administration
-----------------------------
----------------------------------------------------------
Prior And Concomitant Medications
-----------------------------
----------------------------------------------------------
Prior And Concomitant Procedures
-----------------------------
----------------------------------------------------------
Ev, Med, Proc And Study Treatment Summary
-----------------------------
----------------------------------------------------------
End of Study Treatment
-----------------------------
----------------------------------------------------------
Adverse Events
-----------------------------
